ArticleExperimental hematology & oncology2013

Impressive thrombocytosis evolving in a patient with a BCR-ABL positive CML in major molecular response during dasatinib treatment unmasks an additional JAK2V617F.

Friederike Pastore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.